This HTML5 document contains 190 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n6http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n3http://linked.opendata.cz/ontology/sukl/
n20http://linked.opendata.cz/resource/sukl/specialization-restriction/
skoshttp://www.w3.org/2004/02/skos/core#
n15http://linked.opendata.cz/resource/sukl/indgroup/
n14http://linked.opendata.cz/resource/sukl/packing/
n4http://linked.opendata.cz/resource/sukl/company/
n18http://linked.opendata.cz/resource/sukl/active-ingredient/
n11http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147861/price-of-originator/
n16http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147861/reimbursement/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/sukl/registration-state/
n9http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147861/
n5http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147861/core-reimbursement/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://www.sukl.cz/modules/medication/
n13http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0147861/price/
n19http://linked.opendata.cz/resource/sukl/df/
n7http://linked.opendata.cz/resource/atc/

Statements

Subject Item
n2:0147861
rdf:type
n3:MedicinalProductPackaging
dcterms:title
ASTEXANA 25 MG
skos:notation
0147861
n3:hasATCCode
n7:L02BG06
n3:hasActiveIngredient
n18:EXEMESTANUM
n3:hasDefinedDailyDose
n9:ddd
n3:hasDosageForm
n19:TBL-FLM-POR
n3:hasPackagingSize
30
n3:hasPacking
n14:BLI
n3:hasRegistrationHolder
n4:VOWPL
n3:hasRegistrationState
n8:R
n3:hasRouteOfAdministration
n6:POR
n3:hasStrength
25MG
n3:hasIndicationGroup
n15:44
n3:hasSpecializationRestriction
n20:ONK
n3:containsDefinedDailyDoses
30.0
n3:hasRegistrationCode
44/ 436/10-C
n3:hasTitleSupplement
POR TBL FLM 30X25MG
n3:containsUsualTherapeuticalDailyDoses
30
n3:hasBreakMarketingDate
2013-04-05+02:00
n3:hasCoreReimbursementSpecification
n5:2014-12-01 n5:2015-01-01 n5:2014-11-01 n5:2014-11-19 n5:2014-10-01 n5:2014-10-02 n5:2014-08-01 n5:2014-09-01 n5:2015-06-01 n5:2015-07-01 n5:2015-04-02 n5:2015-05-01 n5:2015-03-01 n5:2015-04-01 n5:2015-01-13 n5:2015-02-01 n5:2015-07-02 n5:2013-05-01 n5:2013-06-01 n5:2013-03-01 n5:2013-04-01 n5:2013-01-05 n5:2013-02-01 n5:2013-01-01 n5:2013-12-01 n5:2014-01-01 n5:2013-10-01 n5:2013-11-01 n5:2013-08-03 n5:2013-09-01 n5:2013-07-01 n5:2013-08-01 n5:2014-07-01 n5:2014-07-03 n5:2014-06-01 n5:2014-06-13 n5:2014-04-01 n5:2014-05-01 n5:2014-02-01 n5:2014-03-01
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n11:2013-08-03 n11:2013-09-01 n11:2013-07-01 n11:2013-08-01 n11:2013-12-01 n11:2014-01-01 n11:2013-10-01 n11:2013-11-01 n11:2013-01-05 n11:2013-02-01 n11:2013-01-01 n11:2013-05-01 n11:2013-06-01 n11:2013-03-01 n11:2013-04-01 n11:2015-07-02 n11:2015-03-01 n11:2015-04-01 n11:2015-01-13 n11:2015-02-01 n11:2015-06-01 n11:2015-07-01 n11:2015-04-02 n11:2015-05-01 n11:2014-10-01 n11:2014-10-02 n11:2014-08-01 n11:2014-09-01 n11:2014-12-01 n11:2015-01-01 n11:2014-11-01 n11:2014-11-19 n11:2014-04-01 n11:2014-05-01 n11:2014-02-01 n11:2014-03-01 n11:2014-07-01 n11:2014-07-03 n11:2014-06-01 n11:2014-06-13
n3:hasPriceSpecification
n13:2013-03-01 n13:2013-04-01 n13:2013-05-01 n13:2013-06-01 n13:2013-01-01 n13:2013-01-05 n13:2013-02-01 n13:2015-04-02 n13:2015-05-01 n13:2015-06-01 n13:2015-07-01 n13:2015-01-13 n13:2015-02-01 n13:2015-03-01 n13:2015-04-01 n13:2014-11-01 n13:2014-11-19 n13:2014-12-01 n13:2015-01-01 n13:2014-08-01 n13:2014-09-01 n13:2014-10-01 n13:2014-10-02 n13:2014-06-01 n13:2014-06-13 n13:2014-07-01 n13:2014-07-03 n13:2014-02-01 n13:2014-03-01 n13:2014-04-01 n13:2014-05-01 n13:2013-10-01 n13:2013-11-01 n13:2013-12-01 n13:2014-01-01 n13:2013-07-01 n13:2013-08-01 n13:2013-08-03 n13:2013-09-01 n13:2015-07-02
n3:hasReimbursementSpecification
n16:2014-12-01 n16:2015-01-01 n16:2014-11-01 n16:2014-11-19 n16:2014-10-01 n16:2014-10-02 n16:2014-08-01 n16:2014-09-01 n16:2014-07-01 n16:2014-07-03 n16:2014-06-01 n16:2014-06-13 n16:2014-04-01 n16:2014-05-01 n16:2014-02-01 n16:2014-03-01 n16:2013-12-01 n16:2014-01-01 n16:2013-10-01 n16:2013-11-01 n16:2013-08-03 n16:2013-09-01 n16:2013-07-01 n16:2013-08-01 n16:2013-05-01 n16:2013-06-01 n16:2013-03-01 n16:2013-04-01 n16:2013-01-05 n16:2013-02-01 n16:2013-01-01 n16:2015-07-02 n16:2015-06-01 n16:2015-07-01 n16:2015-04-02 n16:2015-05-01 n16:2015-03-01 n16:2015-04-01 n16:2015-01-13 n16:2015-02-01
n3:hasResumedMarketingDate
2013-05-28+02:00 2011-05-01+02:00
n3:hasUsualTherapeuticalDailyDose
n9:utdd
n3:pilFile
http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DPI61958.pdf%26type%3Dpil%26as%3Dastexana-25-mg-pil
n3:pilUri
n10:download.php?file=PI61958.pdf&type=pil&as=astexana-25-mg-pil
n3:spcFile
http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC53401.pdf%26type%3Dspc%26as%3Dastexana-25-mg-spc
n3:spcUri
n10:download.php?file=SPC53401.pdf&type=spc&as=astexana-25-mg-spc
n3:textOnTheWrapFile
http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DOBAL42057.pdf%26type%3Dobal%26as%3Dastexana-25-mg-obal
n3:textOnTheWrapUri
n10:download.php?file=OBAL42057.pdf&type=obal&as=astexana-25-mg-obal